AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ALBENDAZOLE BP
8 registrations across 4 African markets— 3 active
Markets with ALBENDAZOLE BP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| BEKRAZOL 200/5 SUSPENSION | 🇷🇼Rwanda | BAROQUE PHARMACEUTICALS PVT. LTD | active | Sept 2029 |
| WOMNIL SUSPENSION SUSPENSION | 🇷🇼Rwanda | DAWA LIMITED | active | Jul 2029 |
| NILWORM SUSPENSION Oral Suspension | 🇰🇪Kenya | GALAXY PHARMACEUTICAL LTD | active | Feb 2027 |
| ALBENDAZOLE TABLETS 1 X 1 | 🇳🇬Nigeria | VISKO PHARMACY LTD 2C | expired | Mar 2022 |
| DANZEL TABLETS 1 X 1 | 🇳🇬Nigeria | SUITELIFE PHARMACEUTICALS LTD 4 | expired | Mar 2022 |
| ALBAFAS-ORAL-SUSPENSION 10% ORAL DRENCH ORAL DRENCH | 🇲🇼Malawi | — | expired | Jun 2021 |
| ASHIALBEN_300 300MG BOLUS BOLUS | 🇲🇼Malawi | — | expired | Jun 2014 |
| ALBENDAZOLE 200MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2010 |
ALBENDAZOLE BP in Africa — Regulatory Overview
ALBENDAZOLE BP is registered across 4 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Nigeria, Rwanda, Kenya. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 3 (38%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.